Pay in 4 interest-free payments of $7.33 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
This precision-health approach is especially valuable for bariatric patients who've already invested in surgery and want to maximize the next phase of their weight loss journey
Patients are encouraged to report suspected side effects via the MHRA Yellow Card Scheme
If you shake hard enough, you can actually see the solution become cloudy or foamy, which is a visible sign of peptide degradation
Canadian researchers should budget appropriately and prioritize compound quality over trying to save money on questionable sources
The TRIUMPH-4 Phase 3 trial in obesity with knee osteoarthritis (Bays et al., NEJM 2025) reported 28.7% mean weight loss at 68 weeks at the 12 mg dose, plus a 75.8% reduction in WOMAC knee pain scores
US$ 22.60
US$ 21.04
US$ 23.37
US$ 29.74
